NCT02335931

Brief Summary

The project concerns a type of very debilitating diabetic foot complications called Charcots osteoarthropathy (COA). This disease is characterized by a rapidly progressing destruction of the load bearing joints, primarily in the feet, resulting in loss of structure and remodeling. Untreated this cascade leads to the collapse of the bones, meaning severe pain and walking disability for the patient. Reconstruction is often very difficult or impossible, and furthermore the collapse can lead to chronic foot ulcers and infections, which in the worst case can be fatal. Treatment options are currently limited to early diagnosis and physical offloading (immobilisation), assisted wound healing and surgical intervention. The purpose of this project is to investigate and describe the bone-related factors, which separate COA from other, less acute, diabetic foot changes. The investigators wish to describe the long term consequences of COA - both anatomically, physiologically and biochemically. The investigators will be doing this in a follow-up investigations on a group of COA patients tested 8 years ago. Little is known of the long term changes to the bone structure after acute COA, and the investigators want to visualize to what extend the bone damage is permanent. To do this the investigators will be using DXA-scans, x-ray, blood tests including bone markers, neurophysiological tests and occlusion plethysmography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 12, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

2.3 years

First QC Date

June 27, 2014

Last Update Submit

March 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Disease progression in the previously affected foot

    initiation

Secondary Outcomes (4)

  • Bone mineral density of os. calcaneus

    initiation

  • Peripheral neuropathy in the feet

    initiation

  • Peripheral blood supply

    initiation

  • Altered levels of bone resorption markers

    initiation

Other Outcomes (2)

  • Amputations

    initiation

  • Diabetes regulation

    initiation

Study Arms (2)

Charcot foot

Patients with Charcot foot and diabetes mellitus 1 or 2

No charcot foot

patients with diabetes mellitus type 1 or 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Follow-up study, population of patients referred with charcot foot 8 years ago. Control population without Charcot foot, taken from the outpatient clinic.

You may qualify if:

  • Followed in the previous study

You may not qualify if:

  • Unable to attend follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg Hospital

København NV, 2400, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Frozen full blood samples

MeSH Terms

Conditions

Arthropathy, NeurogenicDiabetes Complications

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesDiabetes MellitusEndocrine System Diseases

Study Officials

  • Rasmus B Jansen, MD

    Bispebjerg Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 27, 2014

First Posted

January 12, 2015

Study Start

September 1, 2014

Primary Completion

January 1, 2017

Study Completion

July 1, 2017

Last Updated

March 31, 2020

Record last verified: 2020-03

Locations